KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
11.90
-0.29 (-2.42%)
At close: May 9, 2025, 4:00 PM
12.49
+0.60 (5.00%)
After-hours: May 9, 2025, 5:39 PM EDT
KalVista Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for KalVista Pharmaceuticals stock ranges from a low of $19 to a high of $30. The average price target of $24.83 forecasts a 108.74% increase in the stock price over the next year.
Price Target: $24.83 (+108.74%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 8, 2025.
Analyst Ratings
The average analyst rating for KalVista Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 5 | 5 | 5 | 5 | 5 |
Buy | 2 | 3 | 3 | 3 | 3 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +135.39% | Apr 8, 2025 |
Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +135.39% | Mar 26, 2025 |
Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $19 | Buy | Reiterates | $19 | +59.73% | Mar 26, 2025 |
Jones Trading | Jones Trading | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +152.21% | Mar 26, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +68.14% | Mar 14, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
31.44M
EPS This Year
-3.60
from -3.44
EPS Next Year
-3.07
from -3.60
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | n/a | 58.2M | 148.2M | |||
Avg | n/a | 31.4M | 112.2M | |||
Low | n/a | 15.4M | 43.1M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | - | - | 371.4% | |||
Avg | - | - | 256.9% | |||
Low | - | - | 37.1% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | -3.51 | -2.53 | -1.04 | |||
Avg | -3.60 | -3.07 | -1.91 | |||
Low | -3.59 | -3.68 | -2.69 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.